Search

Russia administers first domestic personalized cancer vaccine to patient in Kursk

Russia's Health Ministry announced the first patient administration of a domestically developed personalized cancer vaccine, administered to a 60-year-old in Kursk Region. Details on vaccine platform, efficacy data, clinical trial phase, and the specific cancer type are absent from the announcement. This claim requires verification of trial design, regulatory status, and comparative standing against established personalized cancer immunotherapies.